Cytiva webinars and podcasts
-
Strategies For Scaling Up mRNA Manufacturing
4/11/2022
The clinical promise of mRNA therapeutics and vaccines is clear, but compared to monoclonal antibodies or viral vectors, their novelty also brings new challenges to the manufacturing process.
This website uses cookies to ensure you get the best experience on our website. Learn more